Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04535310 · ClinicalTrials.gov registry record · NA
Wear Experience With Daily Contact Lenses Over a Long Day
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04535310: Completed NA study, sponsored by Ohio State University.
NCT04535310 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04535310, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study is evaluating the wear experience of a daily contact lens after 10, 12, 14, and 16 hours of lens wear.
Primary Outcome
Subjective overall comfort as assessed using the Visual Analog Scale (VAS), with a scale of 0 to 100 with 0 being poor and 100 being excellent.
Interventions
- DEVICE Precision1® Daily Disposable Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
What the finished NCT04535310 record still lists
NCT04535310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Precision1® Daily Disposable Contact Lens is the first listed.
NCT04535310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04535310 about?
NCT04535310 is a clinical study titled "Wear Experience With Daily Contact Lenses Over a Long Day". This study is evaluating the wear experience of a daily contact lens after 10, 12, 14, and 16 hours of lens wear.
What is the current status of trial NCT04535310?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-10-13. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT04535310?
The interventions under investigation include: Precision1® Daily Disposable Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT04535310?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04535310's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI